SCLX Stock Analysis: Buy, Sell, or Hold?
SCLX - Scilex Holding Company Common Stock
$5.43
-0.14 (-2.51%)
▼
5d:
-5.24%
30d:
-17.73%
90d:
-38.99%
WAIT
LOW Confidence
Analysis Updated: Aug 28, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When SCLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SCLX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SCLX shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.47
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.64
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SCLX is currently trading at $5.43, which is considered oversold relative to its 30-day fair value range of $5.88 to $6.97. The stock's valuation (Forward PE: 7.4) is in line with its historical norms (7.3). At these levels, the market is pricing in 0.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SCLX is showing sideways momentum. The price is currently testing key support at $5.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $490.00 (+8924.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SCLX is showing sideways momentum. The price is currently testing key support at $5.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $490.00 (+8924.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.88 -
$6.97
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 8924.0% below Wall St target ($490.00)
- NEUTRAL: Market pricing in 0.7% annual earnings growth - fairly valued
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$5.88 -
$6.97
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$5.40
Resistance Level
$6.72
Current Trend
Sideways
Technical data as of
Aug 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.44
Wall Street Target
$490.00
(+8924.0%)
Revenue Growth (YoY)
-22.8%
Valuation Premium vs History
+0.7% premium
PE vs Historical
7.4 vs 7.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.7%
(market-implied from PE analysis)
1-Year Target
$5.47
(+1%)
2-Year Target
$5.51
(+1%)
3-Year Target
$5.54
(+2%)
3-Yr Target (if PE normalizes)
(PE: 7→7)
PE COMPRESSION
$5.44
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 30, 2026 2:12 AM ET
Data refreshes hourly during market hours. Next update: 3:12 AM
Data refreshes hourly during market hours. Next update: 3:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1315 | 52 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$157 | 41 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$277 | 51 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$236 | 43 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$388 | 41 HOLD |
